P2RX7 and cancer: P2X7 receptor is abundantly expressed in cancer cells of leukemia, neuroblastoma, melanoma, as well as in prostate, breast and thyroid cancer [7,8,9,10,11], and has been proposed to be a biomarker for early stage cancer [9,12,13].